Sanofi
venglustat
type 3 Gaucher disease
Date
TBD
Phase 3 readout · Date TBD estimated
What's at stake
Phase 3 trial results for venglustat in type 3 Gaucher disease are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 11h ago
“positive phase 3 study readout for venglustat in rare diseases”